Research Article
INKA2-AS1 Is a Potential Promising Prognostic-Related Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
Table 1
Correlation of INKA2-AS1 expression with clinicopathological features of HCC.
| Characteristic | Low expression of INKA2-AS1 | High expression of INKA2-AS1 | |
| | 187 | 187 | | Age (, %) | | | 0.874 | ≤60 | 90 (24.1%) | 87 (23.3%) | | >60 | 97 (26%) | 99 (26.5%) | | Gender (, %) | | | 0.015 | Female | 49 (13.1%) | 72 (19.3%) | | Male | 138 (36.9%) | 115 (30.7%) | | Histologic grade (, %) | | | 0.036 | G1 | 36 (9.8%) | 19 (5.1%) | | G2 | 91 (24.7%) | 87 (23.6%) | | G3 | 52 (14.1%) | 72 (19.5%) | | G4 | 6 (1.6%) | 6 (1.6%) | | Vascular invasion (, %) | | | 0.217 | No | 113 (35.5%) | 95 (29.9%) | | Yes | 51 (16%) | 59 (18.6%) | | Residual tumor (, %) | | | 0.220 | R0 | 168 (48.7%) | 159 (46.1%) | | R1 | 6 (1.7%) | 11 (3.2%) | | R2 | 1 (0.3%) | 0 (0%) | | Pathologic stage (, %) | | | 0.023 | Stage I | 100 (28.6%) | 73 (20.9%) | | Stage II | 37 (10.6%) | 50 (14.3%) | | Stage III | 35 (10%) | 50 (14.3%) | | Stage IV | 2 (0.6%) | 3 (0.9%) | | T stage (, %) | | | 0.030 | T1 | 105 (28.3%) | 78 (21%) | | T2 | 39 (10.5%) | 56 (15.1%) | | T3 | 35 (9.4%) | 45 (12.1%) | | T4 | 5 (1.3%) | 8 (2.2%) | | M stage (, %) | | | 1.000 | M0 | 133 (48.9%) | 135 (49.6%) | | M1 | 2 (0.7%) | 2 (0.7%) | | N stage (, %) | | | 0.122 | N0 | 129 (50%) | 125 (48.4%) | | N1 | 0 (0%) | 4 (1.6%) | | Age (median, IQR) | 61 (52, 69) | 62 (51, 68) | 0.492 |
|
|